Search - tctmd.com

Displaying 21 - 29 of 29

Sort: Relevancy | Date

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

One Year Outcomes of Left Atrial to Coronary Sinus Shunting for Treatment of Symptomatic Heart Failure; The ALT FLOW Early Feasibility Study One Year Results

Presenter: Firas Zahr

March 05, 2024

Presentation THT 2024

Atrial to Coronary Sinus Shunting: Early Experience With APTURE Shunt System

Presenter: Javed Butler

March 05, 2024

Presentation THT 2024

Cinching the Dilated LV From the Coronary Sinus: The Carillon Approach

Presenter: Samir R. Kapadia

March 04, 2024

Presentation THT 2024

Right Left Atrial-to-Coronary Sinus Shunting: The APTURE Program

Presenter: Firas Zahr

March 04, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

Advertisement

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

What’s Going to Be Hot at ACC 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

One Year Outcomes of Left Atrial to Coronary Sinus Shunting for Treatment of Symptomatic Heart Failure; The ALT FLOW Early Feasibility Study One Year Results

Atrial to Coronary Sinus Shunting: Early Experience With APTURE Shunt System

Cinching the Dilated LV From the Coronary Sinus: The Carillon Approach

Right Left Atrial-to-Coronary Sinus Shunting: The APTURE Program

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content